Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Biol Chem ; 299(12): 105446, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37949230

ABSTRACT

Increasing evidence suggests that aberrant regulation of sortilin ectodomain shedding can contribute to amyloid-ß pathology and frontotemporal dementia, although the mechanism by which this occurs has not been elucidated. Here, we probed for novel binding partners of sortilin using multiple and complementary approaches and identified two proteins of the neuron-specific gene (NSG) family, NSG1 and NSG2, that physically interact and colocalize with sortilin. We show both NSG1 and NSG2 induce subcellular redistribution of sortilin to NSG1- and NSG2-enriched compartments. However, using cell surface biotinylation, we found only NSG1 reduced sortilin cell surface expression, which caused significant reductions in uptake of progranulin, a molecular determinant for frontotemporal dementia. In contrast, we demonstrate NSG2 has no effect on sortilin cell surface abundance or progranulin uptake, suggesting specificity for NSG1 in the regulation of sortilin cell surface expression. Using metalloproteinase inhibitors and A disintegrin and metalloproteinase 10 KO cells, we further show that NSG1-dependent reduction of cell surface sortilin occurred via proteolytic processing by A disintegrin and metalloproteinase 10 with a concomitant increase in shedding of sortilin ectodomain to the extracellular space. This represents a novel regulatory mechanism for sortilin ectodomain shedding that is regulated in a neuron-specific manner. Furthermore, this finding has implications for the development of strategies for brain-specific regulation of sortilin and possibly sortilin-driven pathologies.


Subject(s)
Adaptor Proteins, Vesicular Transport , Carrier Proteins , Metalloproteases , Nerve Tissue Proteins , Neurons , Adaptor Proteins, Vesicular Transport/metabolism , Biotinylation , Brain/cytology , Brain/metabolism , Brain/pathology , Carrier Proteins/metabolism , Disintegrins/deficiency , Disintegrins/genetics , Disintegrins/metabolism , Frontotemporal Dementia/metabolism , Metalloproteases/antagonists & inhibitors , Metalloproteases/metabolism , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Progranulins/metabolism , Protein Binding , Proteolysis , Cell Membrane/metabolism , Amyloid beta-Peptides/metabolism
2.
J Biol Chem ; 293(10): 3510-3523, 2018 03 09.
Article in English | MEDLINE | ID: mdl-29352106

ABSTRACT

The serotonin transporter (SERT) is important for reuptake of the neurotransmitter serotonin from the synaptic cleft and is also the target of most antidepressants. It has previously been shown that cholesterol in the membrane bilayer affects the conformation of SERT. Although recent crystal structures have identified several potential cholesterol-binding sites, it is unclear whether any of these potential cholesterol sites are occupied by cholesterol and functionally relevant. In the present study, we focus on the conserved cholesterol site 1 (CHOL1) located in a hydrophobic groove between TM1a, TM5, and TM7. By molecular dynamics simulations, we demonstrate a strong binding of cholesterol to CHOL1 in a membrane bilayer environment. In biochemical experiments, we find that cholesterol depletion induces a more inward-facing conformation favoring substrate analog binding. Consistent with this, we find that mutations in CHOL1 with a negative impact on cholesterol binding induce a more inward-facing conformation, and, vice versa, mutations with a positive impact on cholesterol binding induce a more outward-facing conformation. This shift in transporter conformation dictated by the ability to bind cholesterol in CHOL1 affects the apparent substrate affinity, maximum transport velocity, and turnover rates. Taken together, we show that occupation of CHOL1 by cholesterol is of major importance in the transporter conformational equilibrium, which in turn dictates ligand potency and serotonin transport activity. Based on our findings, we propose a mechanistic model that incorporates the role of cholesterol binding to CHOL1 in the function of SERT.


Subject(s)
Cholesterol/metabolism , Lipid Bilayers/metabolism , Models, Molecular , Serotonin Plasma Membrane Transport Proteins/metabolism , Amino Acid Substitution , Binding Sites , Binding, Competitive , Biological Transport/drug effects , Cholesterol/chemistry , Conserved Sequence , HEK293 Cells , Humans , Hydrophobic and Hydrophilic Interactions , Kinetics , Ligands , Lipid Bilayers/chemistry , Molecular Dynamics Simulation , Mutagenesis, Site-Directed , Mutation , Protein Conformation , Protein Interaction Domains and Motifs , Protein Stability , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Serotonin Plasma Membrane Transport Proteins/chemistry , Serotonin Plasma Membrane Transport Proteins/genetics , beta-Cyclodextrins/chemistry , beta-Cyclodextrins/metabolism
3.
Genes Brain Behav ; 21(6): e12816, 2022 07.
Article in English | MEDLINE | ID: mdl-35577358

ABSTRACT

The Neuron-specific gene family (NSG1-3) consists of small endolysosomal proteins that are critical for trafficking multiple receptors and signaling molecules in neurons. NSG1 has been shown to play a critical role in AMPAR recycling from endosomes to plasma membrane during synaptic plasticity. However, to date nothing is known about whether NSG1 is required for normal behavior at an organismal level. Here we performed a battery of behavioral tests to determine whether loss of NSG1 would affect motor, cognitive, and/or affective behaviors, as well as circadian-related activity. Consistent with unique cerebellar expression of NSG1 among family members, we found that NSG1 was obligatory for motor coordination but not for gross motor function or learning. NSG1 knockout (KO) also altered performance across other behavioral modalities including anxiety-related and diurnal activity paradigms. Surprisingly, NSG1 KO did not cause significant impairments across all tasks within a given modality, but had specific effects within each modality. For instance, we found increases in anxiety-related behaviors in tasks with multiple stressors (e.g., elevation and exposure), but not those with a single main stressor (e.g., exposure). Interestingly, NSG1 KO animals displayed a significant increase in locomotor activity during subjective daytime, suggesting a possible impact on diurnal activity rhythms or vigilance. Surprisingly, loss of NSG1 had no effect on hippocampal-dependent learning despite previous studies showing deficits in CA1 long-term potentiation. Together, these findings do not support a role of NSG1 in hippocampal-dependent learning, but support a role in mediating proper neuronal function across amygdalar and cerebellar circuits.


Subject(s)
Hippocampus , Neurons , Animals , Anxiety/genetics , Endosomes/metabolism , Hippocampus/metabolism , Male , Mice , Mice, Knockout , Neuronal Plasticity/physiology , Neurons/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL